INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies.
Benjamin, Richard J
INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies. [electronic resource] - Transfusion 04 2020 - 881-882 p. digital
Publication Type: Letter
1537-2995
10.1111/trf.15722 doi
Blood Platelets--immunology
Humans
Isoantibodies--immunology
Platelet Transfusion--adverse effects
INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies. [electronic resource] - Transfusion 04 2020 - 881-882 p. digital
Publication Type: Letter
1537-2995
10.1111/trf.15722 doi
Blood Platelets--immunology
Humans
Isoantibodies--immunology
Platelet Transfusion--adverse effects